Lotus Pharmaceutical Co., Ltd. (TPE:1795)
283.00
+3.00 (1.07%)
At close: Dec 31, 2025
4.43% (1Y)
| Market Cap | 74.42B |
| Revenue (ttm) | 18.66B |
| Net Income (ttm) | 4.73B |
| Shares Out | 262.98M |
| EPS (ttm) | 18.04 |
| PE Ratio | 15.69 |
| Forward PE | 11.05 |
| Dividend | 5.78 (2.04%) |
| Ex-Dividend Date | Aug 11, 2025 |
| Volume | 1,725,335 |
| Average Volume | 2,178,262 |
| Open | 279.00 |
| Previous Close | 280.00 |
| Day's Range | 276.00 - 283.00 |
| 52-Week Range | 172.50 - 328.00 |
| Beta | 0.17 |
| RSI | 47.38 |
| Earnings Date | Mar 4, 2026 |